Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Relay Therapeutics, Inc. | Director | Common Stock | 67.2K | $339K | $5.04 | Jun 10, 2024 | Direct |
EQRx, Inc. | Chief Financial Officer | Earn-out Shares | 302K | Jan 1, 2023 | Direct | ||
Boundless Bio, Inc. | Chief Financial Officer | Stock Option | 32.5K | Aug 19, 2024 | Direct | ||
Boundless Bio, Inc. | Chief Financial Officer | Stock Option | 32.5K | Mar 27, 2024 | Direct | ||
Relay Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Jun 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BOLD | Boundless Bio, Inc. | Aug 19, 2024 | 6 | $0 | 4 | Aug 20, 2024 | Chief Financial Officer |
RLAY | Relay Therapeutics, Inc. | Jun 10, 2024 | 2 | $213K | 4 | Jun 12, 2024 | Director |
RLAY | Relay Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
BOLD | Boundless Bio, Inc. | Mar 27, 2024 | 1 | $0 | 4 | Mar 29, 2024 | Chief Financial Officer |
BOLD | Boundless Bio, Inc. | Mar 27, 2024 | 0 | $0 | 3 | Mar 27, 2024 | Chief Financial Officer |
RLAY | Relay Therapeutics, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 1, 2023 | Director |
EQRX | EQRx, Inc. | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Chief Financial Officer |
RLAY | Relay Therapeutics, Inc. | May 27, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
EQRX | EQRx, Inc. | Feb 25, 2022 | 1 | $0 | 4 | Mar 1, 2022 | Chief Financial Officer |
EQRX | EQRx, Inc. | Dec 17, 2021 | 2 | $0 | 4 | Dec 20, 2021 | Chief Financial Officer |
EQRX | EQRx, Inc. | Dec 17, 2021 | 0 | $0 | 3 | Dec 20, 2021 | Chief Financial Officer |
RLAY | Relay Therapeutics, Inc. | May 19, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |